JAK-IN-5 hydrochloride

CAS No. 2751323-21-2

JAK-IN-5 hydrochloride( JAK-IN-5 hydrochloride(2096999-92-5 Free base) )

Catalog No. M26264 CAS No. 2751323-21-2

JAK-IN-5 hydrochloride is an inhibitor of JAK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 1224 Get Quote
50MG 1899 Get Quote
100MG 2835 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JAK-IN-5 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    JAK-IN-5 hydrochloride is an inhibitor of JAK.
  • Description
    JAK-IN-5 hydrochloride is an inhibitor of JAK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    JAK-IN-5 hydrochloride(2096999-92-5 Free base)
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    TRPML1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2751323-21-2
  • Formula Weight
    511.03
  • Molecular Formula
    C27H32ClFN6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H]Cl.OC1=CC(CC)=C(C2=CC3=C(C=C2)C(C(N4)=NC5=C4CN(C6CCN(C)CC6)CC5)=NN3)C=C1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chen CC, Keller M et al. A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV. Nat Commun. 2014 Aug 14;5:4681.
molnova catalog
related products
  • WHI-P97

    A potent, specific JAK3 inhibitor with Ki of 0.6-2.3 uM.

  • Povorcitinib phospha...

    Povorcitinib phosphate is a selective JAK1 inhibitor and can be used in studies about the treatment of cutaneous lupus erythematosus and Lichen planus.

  • Izencitinib

    Izencitinib (JNJ-8398) is an orally active and gut-selective JAK inhibitor with potential anti-inflammatory activity for the study of ulcerative colitis and Crohn;s disease.